Private Equity

Italian luxury knitwear maker Zanieri completes a reverse merger with Everlert, Inc., gaining a US public listing to fund global expansion and brand growth.

After a year of major acquisitions and AI-driven innovation, all eyes are on Labcorp's strategic vision for 2026 at the J.P. Morgan Healthcare Conference.

Treace Medical heads to the J.P. Morgan conference to showcase its surgical tech, facing tough questions on growth amid competition and market shifts.

INVO Fertility realigns its top brass, positioning a deal-making veteran to lead an aggressive clinic acquisition strategy in a booming market.

Hyatt finalizes a $2B asset sale to Tortuga Resorts, advancing its asset-light strategy while navigating hurricane recovery in the Caribbean.

Investors await Polaris's Q4 results on Jan. 27, seeking clarity on market share gains, tariff impacts, and the future of its Indian Motorcycle brand.

The investment firm renews its plan to repurchase up to 5% of its units, signaling a strong belief that its market price is below its intrinsic value.

In a strategic move signaling confidence in American nuclear energy, IsoEnergy has significantly increased its ownership in Premier American Uranium.

Facing market headwinds, tea supplier Oriental Rise makes a bold move to acquire a major producer, aiming to secure its supply chain and boost quality.

With a new $500 million credit line, Ramaco Resources is doubling down on its unique strategy: growing its coal business while racing to develop a US rare earth mine.

Amid economic headwinds, the M&A advisor thrived by securing over 90 deals and promoting key partners, signaling strong momentum for healthcare sales in 2026.

KKR's landmark purchase of Cheongna Logistics Center, the largest in Korea, signals a massive bet on the nation's booming e-commerce infrastructure.

Peruvian financial giant Credicorp is buying Florida's Helm Bank, a strategic move to capture the lucrative cross-border wealth of Latin American clients.

The biopharma investment giant has now acquired 100% of the royalty stream for Roche's blockbuster SMA drug, a strategic move years in the making.

Just months after its IPO, Kandal M Venture is fighting to stay on Nasdaq. We explore the financial woes behind the stock's dramatic fall.

Influential advisory firm ISS backs Blue Ant's acquisition of Thunderbird, citing a 50% premium and boosting prospects for a Canadian media mega-merger.

After eliminating over $10.7M in debt, cannabis operator LEEF Brands leverages strong Q3 growth to fuel major expansion in California and New York.

After selling its Oklahoma assets, Amplify Energy has eliminated its debt and is now focusing its capital on high-potential Beta and Bairoil fields.

Kite Realty Group declared a special dividend for shareholders. We dig into whether this signals a healthy retail market or is simply a savvy tax strategy.

A private tender offer values diagnostics firm PathoCare at $1.75B. Can its AI-powered, non-invasive technology justify the price and transform medicine?